| abstract |
The invention discloses a thieno[3.2-c]pyridine containing acetyl hydrazine derivative or a salt chemically acceptable of the derivative; meanwhile, the invention also discloses a drug combination with the compounds as active-effective components and an application of the same as a medicine for treating platelet aggregation inhibitor, and particularly for preparing, preventing or curing diseases due to the platelet aggregation, such as coronary syndrome, myocardial infarction, myocardial ischemia and cardio-cerebrovascular diseases. |